Q32 Bio Inc (QTTB) Stock Price, Quote & News

Company Profile

Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic derm...

Industry: Biotechnology

Sector: Healthcare

Phone: 781 999 0232

Website: www.q32bio.com

Address:

830 Winter Street, Waltham, United States

silentmaxx Jul. 1 at 1:51 PM

$QTTB

0 · Reply

silentmaxx Jun. 25 at 4:25 PM

$QTTB

0 · Reply

NotHopeJustFacts Jun. 5 at 2:15 PM

$QTTB guess nobody want to buy their alopecia shampoo... LMAO

0 · Reply

Hanaleimike Jun. 4 at 3:16 PM

$QTTB for the FIXX folks. Does anyone know when we get paid for the cvro’s

1 · Reply

ALOSETE Jun. 3 at 7:20 PM

$QTTB smelling news inminent.

1 · Reply

ALOSETE Jun. 2 at 3:23 PM

$QTTB strong accumulation for several months. Explosive movement is in the cards.

0 · Reply

ALOSETE Jun. 2 at 3:02 PM

$QTTB expecting news this week or next.

0 · Reply

ALOSETE May. 29 at 8:53 AM

$QTTB Some news arround the corner before June General Meeting. Finacing , colaboration or interin data in the cards. Yesterday volume was better. Today could touch 2s.

0 · Reply

ALOSETE May. 28 at 4:36 PM

$QTTB ready to explode.

0 · Reply

ALOSETE May. 28 at 4:21 PM

$QTTB smelling news soon

0 · Reply

Q32 Bio Appoints Adrien Sipos, M.D., Ph.D., as Interim Chief Medical Officer

May 8, 2025, 6:59 AM EDT - 2 months ago

Q32 Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update

Apr 30, 2025, 6:59 AM EDT - 2 months ago

Q32 Bio Announces FDA Fast Track Designation Granted to Bempikibart (ADX-914) for the Treatment of Alopecia Areata

Apr 16, 2025, 6:59 AM EDT - 2 months ago

Q32 Bio Doses First Patients in Both Part A Open-Label Extension and Part B of SIGNAL-AA Phase 2a Trial Evaluating Bempikibart in Alopecia Areata

Mar 11, 2025, 6:59 AM EDT - 4 months ago

Q32 Bio Reports Fourth Quarter 2024 Financial Results and Provides Corporate Update

Mar 8, 2025, 11:00 AM EST - 4 months ago

Q32 Bio Presents Results from SIGNAL-AA Part A Clinical Trial Evaluating Bempikibart in Patients with Alopecia Areata at the 2025 American Academy of Dermatology Meeting

Feb 28, 2025, 9:00 AM EST - 4 months ago

Q32 Bio Announces Late-Breaking Presentation of Results from SIGNAL-AA Part A Clinical Trial of Bempikibart in Alopecia Areata at the 2025 American Academy of Dermatology Annual Meeting

Feb 26, 2025, 6:59 AM EST - 4 months ago

Q32 Bio to Participate in Upcoming March Investor Conferences

Feb 10, 2025, 4:05 PM EST - 5 months ago

Q32 Bio Announces Strategic Restructuring to Focus on Advancement of Bempikibart in Patients with Alopecia Areata

Feb 4, 2025, 4:05 PM EST - 5 months ago

Q32 Bio to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference

Dec 11, 2024, 11:32 AM EST - 7 months ago

Why Is Skin Disease-Focused Q32 Bio Stock Trading Lower On Wednesday?

Dec 10, 2024, 4:05 PM EST - 7 months ago

Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program

Nov 7, 2024, 6:59 AM EST - 8 months ago

Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 5, 2024, 6:59 AM EST - 8 months ago

Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference

Oct 14, 2024, 6:59 AM EDT - 9 months ago

Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024

Aug 29, 2024, 6:59 AM EDT - 11 months ago

Q32 Bio to Participate in Upcoming September Investor Conferences

Aug 29, 2024, 3:40 AM EDT - 11 months ago

Q32 Bio: High-Risk, High-Reward With Bempikibart And ADX-097

Aug 1, 2024, 4:54 PM EDT - 1 year ago

8 Best-Performing Small Caps In July: Find Out Which Stock Jumped 803%

AIU COMM EBS HE HUMA SAVA SERV

Jul 9, 2024, 6:59 AM EDT - 1 year ago

Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic Dermatitis

Jul 1, 2024, 6:59 AM EDT - 1 year ago

Q32 Bio Joins Russell 3000® Index

May 9, 2024, 6:59 AM EDT - 1 year ago

Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update

Apr 3, 2024, 7:00 AM EDT - 1 year ago

Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer

Mar 25, 2024, 4:15 PM EDT - 1 year ago

Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million

silentmaxx Jul. 1 at 1:51 PM

$QTTB

0 · Reply

silentmaxx Jun. 25 at 4:25 PM

$QTTB

0 · Reply

NotHopeJustFacts Jun. 5 at 2:15 PM

$QTTB guess nobody want to buy their alopecia shampoo... LMAO

0 · Reply

Hanaleimike Jun. 4 at 3:16 PM

$QTTB for the FIXX folks. Does anyone know when we get paid for the cvro’s

1 · Reply

ALOSETE Jun. 3 at 7:20 PM

$QTTB smelling news inminent.

1 · Reply

ALOSETE Jun. 2 at 3:23 PM

$QTTB strong accumulation for several months. Explosive movement is in the cards.

0 · Reply

ALOSETE Jun. 2 at 3:02 PM

$QTTB expecting news this week or next.

0 · Reply

ALOSETE May. 29 at 8:53 AM

$QTTB Some news arround the corner before June General Meeting. Finacing , colaboration or interin data in the cards. Yesterday volume was better. Today could touch 2s.

0 · Reply

ALOSETE May. 28 at 4:36 PM

$QTTB ready to explode.

0 · Reply

ALOSETE May. 28 at 4:21 PM

$QTTB smelling news soon

0 · Reply

ALOSETE May. 26 at 9:50 PM

$QTTB Time for some good news before general meeting 13 June?

0 · Reply

garygb May. 26 at 7:48 PM

$QTTB Oversold

0 · Reply

ALOSETE May. 19 at 5:52 PM

$QTTB waiting volume.

0 · Reply

ALOSETE May. 16 at 7:05 PM

$QTTB Wilde movement cooking here.

0 · Reply

ALOSETE May. 16 at 6:55 PM

$QTTB Buying pressure its obvious. I think is ready to blow next week.

0 · Reply

ALOSETE May. 16 at 1:52 PM

$QTTB Ready to go

0 · Reply

ALOSETE May. 16 at 9:11 AM

$QTTB We are ready to breakout 1.77 and go 2-2.15$

0 · Reply

ALOSETE May. 15 at 9:41 PM

$QTTB The weak are out, but only the veteran traders/ investors can see this opportunity at the rigth pps. Now its the time.

0 · Reply

ALOSETE May. 15 at 9:36 PM

$QTTB with a offering of course.

0 · Reply

oaksapollo May. 15 at 9:23 PM

$QTTB nobody can answer this

1 · Reply

BigDaddy_LongTrades May. 15 at 6:42 PM

$QTTB Any Homology folk still waiting on the "pay out?" That is a pipe dream I'm guessing yes?

0 · Reply

ALOSETE May. 15 at 4:42 PM

$QTTB Float is loaded and looked now. Low volume says all st the bottom after huge drop. Any news can blow this at any moment.

0 · Reply

Market Cap	17.57M
Revenue (ttm)	0.00
Net Income (ttm)	-47.73M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	-3.17

Volume	52,800
Avg Vol	142,906
Day's Range	N/A - N/A
Shares Out	12.20M
Stochastic %K	16%
Beta	-0.07
Analysts	Sell
Price Target	$11.00